• English
    • Deutsch
View Item 
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  •   OPARU Home
  • Universitätsklinikum Ulm
  • Publikationsnachweise
  • View Item
  • English 
    • English
    • Deutsch
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma

Erstveröffentlichung
2019
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Halatsch, Marc-Eric
Kast, Richard Eric
Dwucet, Annika
Hlavac, Michal
Heiland, Tim
et al.
Institutions
UKU. Klinik für Neurologie
UKU. Klinik für Neurochirurgie
UKU. Klinik für Kinder- und Jugendmedizin
Published in
British journal of clinical pharmacology ; 176 (2019), 18. - S. 3681-3694. - ISSN 0306-5251. - eISSN 1365-2125
Link to publication
https://dx.doi.org/10.1111/bph.14773
Dewey Decimal Group
DDC 610 / Medicine & health

Metadata
Show full item record

About OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFundingThis CollectionFacultiesInstitutionsPersonsResource typesUlm SerialsDewey Decimal ClassesFunding

My Account

LoginRegister

Statistics

View Usage Statistics

About OPARU | Contact Us
Impressum | Privacy statement